Plasmodium falciparum malaria
MONDO:0005920Malaria resulting from infection by Plasmodium falciparum.
Also known as: Plasmodium falciparum malaria, unspecified, falciparum malaria, falciparum malaria [malignant tertian], malignant tertian fever (finding)
127 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New malaria vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests a new malaria vaccine called PfSPZ-LARC2 in up to 22 healthy adults who have never had malaria. The vaccine uses live but genetically weakened malaria parasites that stop developing late in the liver, aiming to trigger a stronger immune response than …
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 28, 2026 00:00 UTC
-
New malaria vaccine dosing strategy tested in Early-Stage trial
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests whether giving the R21/Matrix-M malaria vaccine in a new, escalating-dose schedule is safe and creates a strong immune response. It involves 36 healthy adults in the UK who have never had malaria. The goal is to find a better way to protect people fro…
Phase: PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:06 UTC
-
Promising malaria vaccine candidates enter key trial in african children
⭐️ VACCINE ⭐️ OngoingThis study tests two experimental malaria vaccines in 360 children aged 5 to 36 months in Burkina Faso, a country where malaria is common. The vaccines aim to prevent malaria caused by the Plasmodium falciparum parasite. Researchers will check how safe the vaccines are, how well …
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC
-
New vaccines aim to block malaria transmission in africa
⭐️ VACCINE ⭐️ OngoingThis study tests two experimental vaccines designed to stop the malaria parasite from spreading from person to person. The vaccines target the parasite's development inside mosquitoes, so vaccinated people who get bitten are less likely to pass the infection on. The trial involve…
Phase: PHASE1, PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC
-
Promising malaria vaccine trial launches for children in burkina faso
⭐️ VACCINE ⭐️ OngoingThis study tests a new malaria vaccine called SUM-101 in 69 healthy children and infants aged 5 months to 5 years in Burkina Faso. The goal is to see if the vaccine is safe and triggers a strong immune response. Participants receive three doses, and some infants also receive a ra…
Phase: PHASE1 • Sponsor: European Vaccine Initiative • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:59 UTC
-
New drug aims to stop transplant attack on the body
Disease control OngoingThis phase 2 trial tests whether the drug itacitinib, given with standard care, can prevent graft-versus-host disease (GVHD) in people who receive a donor stem cell transplant for blood cancers. GVHD happens when the donor cells attack the patient's body. The study includes 31 ad…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Hospital at home: new study tests home care for infections
Disease control OngoingThis study looks at whether a special team of doctors and nurses can treat adults with suspected infections at home, instead of sending them to the hospital. About 500 people will be randomly assigned to either standard hospital care or home-based care from a mobile response team…
Phase: NA • Sponsor: Copenhagen University Hospital at Herlev • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New malaria drug combo shows promise in kids
Disease control OngoingThis study looked at how two different malaria drug combinations work in children with uncomplicated malaria in Zambia. The goal was to see how well the drugs clear malaria parasites from the blood and prevent new infections for up to 9 weeks. About 182 children took part, and re…
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Simple malaria test in early pregnancy could save newborns
Prevention OngoingThis study tests whether screening pregnant women for malaria with a highly sensitive rapid test during the first trimester, followed by treatment if positive, can improve newborn health. Over 2,000 women in malaria-prone areas will be compared to those receiving usual care. The …
Phase: PHASE4 • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Malaria prevention study pulled before it began
Prevention TerminatedThis study aimed to see if sending health workers to find malaria cases in high-risk villages and among forest workers could lower malaria rates better than usual care. It planned to track infections over 18 months in southern Laos. However, the study was withdrawn before any par…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Mass malaria drug campaign aims to stop parasite spread in senegal
Prevention OngoingThis study tests whether giving antimalarial drugs to entire communities can reduce malaria transmission. About 18,000 people in 50 villages in Senegal will take part. The goal is to clear hidden malaria parasites that standard treatments miss, especially during the dry season.
Phase: NA • Sponsor: Institut de Recherche pour le Developpement • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
School-Based malaria prevention could shield entire villages
Prevention OngoingThis study tests whether giving school children preventive malaria medicine can reduce infections not only in them but also in younger siblings at home. About 1,000 students in rural Malawi will receive either one of two drug combinations or no preventive treatment. Researchers w…
Phase: PHASE4 • Sponsor: Liverpool School of Tropical Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Could listening to music ease the stress of stem cell transplants?
Symptom relief OngoingThis pilot study tests whether a daily mindful music listening program is practical and acceptable for patients hospitalized after an allogeneic stem cell transplant. About 35 adults will listen to music for one hour each day using a web-based platform. The study measures how fea…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Art and exercise may boost recovery for kids after transplant
Symptom relief OngoingThis study looks at whether adding art therapy to physical therapy can help children aged 5 to 18 recover emotionally and physically after a stem cell transplant. For two weeks, some children receive both art and physical therapy daily, while others get only physical therapy. Res…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Breastfeeding moms with malaria: do drugs reach baby?
Knowledge-focused OngoingThis study tracks how the malaria drug artemether-lumefantrine passes from a breastfeeding mother into her breastmilk and then into her nursing infant. Researchers will take blood and milk samples from 30 mother-infant pairs in Uganda over two weeks. The goal is to understand dru…
Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Did storing testicular tissue as a child protect fertility? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 50 young men who had cancer or blood disorders as children and received treatments that can harm fertility. Some stored testicular tissue before treatment; others did not. Researchers will check their fertility through exams, ultrasounds, blood tests, and semen…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
AI predicts hospital stays, but study never started
Knowledge-focused TerminatedThis study aimed to see if a computer could learn to predict how long a patient would stay in a home hospital program. Researchers planned to use data from past patients to train the computer. However, the study was withdrawn before any patients were enrolled, so no results are a…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Immune cell showdown: autoimmune vs. infection vs. healthy
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at immune cells from people with autoimmune diseases (like lupus), people with infections, and healthy volunteers. Researchers want to understand how these cells differ and what makes them attack the body in autoimmune conditions. The study involves blood and bon…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC